Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TTBIO Corp. (6493:TWSE), powered by AI.
TTBIO Corp. is currently trading at $26.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for TTBIO Corp. on Alpha Lenz.
View TTBIO Corp.'s valuation metrics on Alpha Lenz.
“TTBIO Corp.'s ROE is -6.5%. Explore profitability and growth together.”
Ask for details →TTBIO Corp. is a healthcare technology company specializing in the design, manufacture, and servicing of medical devices, with a particular focus on dental equipment. The company’s primary offerings include high and low-speed dental handpieces, dental spare parts, service rotors, maintenance units, and electric handpiece systems. These products are utilized extensively in dental care procedures such as tooth repair, shaping, polishing, filling adjustments, porcelain customization, and root canal treatments. In addition to dental-specific devices, TTBIO Corp. produces precision machined components that serve industries beyond healthcare, such as automotive, aerospace, computer hardware, and security systems. Founded in 2012 and headquartered in Taichung, Taiwan, TTBIO Corp. occupies a significant niche within the medical instruments and supplies sector, providing both standard and custom solutions for practitioners and businesses in Taiwan and international markets. The company’s role in the market is underpinned by its emphasis on quality and reliability in precision engineering, supporting a diverse range of industrial clients and expanding access to specialized medical technology.
“TTBIO Corp.'s ROE is -6.5%. Explore profitability and growth together.”
Ask for details →TTBIO Corp. (ticker: 6493) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 118 employees.
The current price is 26 with a P/E ratio of -x and P/B of -x.
ROE is -6.53% and operating margin is -5.21%. Annual revenue is $399M.